Extra-abdominal involvement is associated with antitubercular therapy-related hepatitis in patients treated for abdominal tuberculosis

Saurabh Dawra; Harshal S Mandavdhare; Harjeet Singh; Kaushal K Prasad; Usha Dutta; Vishal Sharma

doi:10.5114/ceh.2019.83158

eISSN: 2449-8238
ISSN: 2392-1099

Clinical and Experimental Hepatology

Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2019
vol. 5

Send email

Copy url:

abstract:

Original paper

Extra-abdominal involvement is associated with antitubercular therapy-related hepatitis in patients treated for abdominal tuberculosis

Saurabh Dawra

¹

,

Harshal S Mandavdhare

¹

,

Harjeet Singh

¹

,

Kaushal K Prasad

¹

,

Usha Dutta

¹

,

Vishal Sharma

¹

Department of Gastroenterology and General Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Clin Exp HEPATOL 2019; 5, 1: 60–64

DOI: https://doi.org/10.5114/ceh.2019.83158

Online publish date: 2019/03/01

View full text Get citation

PlumX metrics:

Aim of the study
Incidence and predictors of antitubercular therapy (ATT)-related hepatitis in abdominal tuberculosis are not known. The aim of the study was to identify the incidence and predictors of ATT-induced hepatitis in abdominal tuberculosis.

Material and methods
A retrospective analysis of patients who received ATT for suspected abdominal tuberculosis with complete follow-up was done. We excluded patients with underlying chronic or acute liver disease necessitating an alteration in the usual ATT at start. We recorded the occurrence of ATT-induced hepatitis and compared patients with and without ATT hepatitis for any predictors of ATT-induced hepatitis.

Results
Of 163 patients, 22 were excluded (17 missing information, 5 chronic liver disease). One hundred and forty-one patients (mean age: 34.33 ±15.18 years, males: 72) were included. The Mantoux test was positive in 78; 1 had HIV and 32 had an abnormal chest X-ray. Six patients had an alternative diagnosis and 11 needed surgery. Forty-nine (34.8%) had extra-abdominal involvement. Ten patients (7.1%) developed ATT-induced hepatitis. Patients with extra-abdominal tubercular involvement had a greater risk of developing ATT-induced hepatitis (p-value 0.003). None of the other parameters including hematological tests, liver function tests and biochemical parameters were different between the two groups.

Conclusions
Seven percent of patients treated for abdominal tuberculosis developed ATT hepatitis. Presence of extra-abdominal involvement was associated with ATT hepatitis.

keywords:

Extra-abdominal involvement is associated with antitubercular therapy-related hepatitis in patients treated for abdominal tuberculosis

Saurabh Dawra 1 , Harshal S Mandavdhare 1 , Harjeet Singh 1 , Kaushal K Prasad 1 , Usha Dutta 1 , Vishal Sharma 1

tuberculosis, drug-induced liver injury, peritoneal tuberculosis, intestinal tuberculosis, hepatitis

Saurabh Dawra

¹

,

Harshal S Mandavdhare

¹

,

Harjeet Singh

¹

,

Kaushal K Prasad

¹

,

Usha Dutta

¹

,

Vishal Sharma

¹